Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.

Journal of surgical oncology - 1 May 2020

Cai Huayong, Zhang Yu, Zhang Haoyun, Cui Chao, Li Chonghui, Lu Shichun

Abstract excerpt

BACKGROUND AND AIM: This study aimed to assess the potential relationship between tumor mutation burden (TMB) and the recurrence risk of hepatocellular cancer (HCC) after curative resection and tried to develop a reliable TMB based nomogram. METHODS: This retrospective study was conducted in 128 patients (40 patients suffered from a recurrence of HCC) who had received radical hepatectomy by the same surgical...

Topics

Join the communities discussing this publication.

Carcinoma, Hepatocellular
Exome Sequencing
Hepatectomy
Liver Neoplasms
Models, Statistical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Neoplasm Recurrence, Local

Treatment Outcome

Source

Identifiers

PMID: 31995247
DOI: 10.1002/jso.25859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.PMID 31995247Read ↗

Tumor Mutational Burden as a Prognostic Biomarker for Relapse-Free Survival in Hepatocellular Carcinoma: Insights from Long-Term Follow-UpSemantic proximity Read ↗

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.Semantic proximity Read ↗

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinomaSemantic proximity Read ↗

Genetic alterations are related to clinicopathological features and risk of recurrence/metastasis of hepatocellular carcinoma.Semantic proximity Read ↗

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic ChemotherapySemantic proximity Read ↗

Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patientsSemantic proximity Read ↗

Prognostic implications of tumor mutation burden in postoperative patients with colorectal cancer who received capecitabine-based adjuvant chemotherapy: a retrospective exploratory studySemantic proximity Read ↗

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinomaSemantic proximity Read ↗

Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.Semantic proximity Read ↗

LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma.Semantic proximity Read ↗

A Simple Nomogram Developed for Predicting HCC Metastasis Based on microRNAsSemantic proximity Read ↗

Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.